MEGHAN BLANCO: Open Payments
NPI 1639893332 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 46 payments from 9 companies in 2025. Trend: 2023 $786 · 2024 $2,082 · 2025 $938
Food & beverage: $938
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $225 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $179 |
| Regeneron Healthcare Solutions, Inc. | 6 | $157 |
| Janssen Biotech, Inc. | 8 | $150 |
| PFIZER INC. | 3 | $73 |
| GENZYME CORPORATION | 2 | $55 |
| Phathom Pharmaceuticals, Inc. | 3 | $37 |
| Celltrion USA Inc. | 2 | $37 |
| Lilly USA, LLC | 1 | $24 |
Products named: DUPIXENT, RINVOQ, TREMFYA, ENTYVIO, XELJANZ, EOHILIA, VOQUEZNA, VEGZELMA.
Industry payments across TX — which companies pay providers there.
